Even if you were to exclude the R&D rebate, it looks like the company is getting quite close towards cashflow breakeven. The short term debt's also been fully repaid during the quarter.
EHS remains on track for $1.5m EBITDA, whilst Sofihub conversion is abit slower but otherwise growth is still very strong yoy.
Overall looks quite good to me.
Even if you were to exclude the R&D rebate, it looks like the...
Add CTQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.533M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 965157 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 572268 | 2 |
View Market Depth
| Last trade - 16.12pm 21/05/2024 (20 minute delay) ? |
| CTQ (ASX) Chart |
Day chart unavailable